EASL 2016: Sofosbuvir, Velpatasvir, and GS-9857 Works Well for Treatment-Experienced HCV Patients

Press/Media: Press / Media

PeriodApr 14 2016

Media coverage

1

Media coverage

  • TitleEASL 2016: Sofosbuvir, Velpatasvir, and GS-9857 Works Well for Treatment-Experienced HCV Patients
    Media name/outletHIV and Hepatitis.com
    CountryUnited States
    Date4/14/16
    PersonsEric J Lawitz